Paroxetine versus other anti-depressive agents for depression-Reference-Cited by-同舟云学术

Paroxetine versus other anti-depressive agents for depression

Published:2014-04-03 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Purgato Marianna¹,Papola Davide¹,Gastaldon Chiara¹,Trespidi Carlotta¹,Magni Laura R²,Rizzo Carla³,Furukawa Toshi A⁴,Watanabe Norio⁵,Cipriani Andrea⁶,Barbui Corrado¹

Affiliation:

1. University of Verona; Department of Public Health and Community Medicine, Section of Psychiatry; Policlinico "G.B.Rossi" Pzz.le L.A. Scuro, 10 Verona Italy 37134

2. Istituto di Ricovero e Cura a Carattere Scientifico, Centro San Giovanni di Dio, Fatebenefratelli; Psychiatric Unit; Brescia Italy

3. Azienda Sanitaria per i Servizi Sanitari ? Provincia Autonoma di Trento; Dipartimento di Salute Mentale; Via Degasperi, 79 Trento Italy 38123

4. Kyoto University Graduate School of Medicine / School of Public Health; Department of Health Promotion and Human Behavior; Yoshida Konoe-cho, Sakyo-ku, Kyoto Japan 606-8501

5. National Center of Neurology and Psychiatry; Department of Clinical Epidemiology; 4-1-1 Ogawa-higashi Kodaira Tokyo Tokyo Japan 187-8551

6. University of Oxford; Department of Psychiatry; Warneford Hospital Oxford UK OX3 7JX

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD006531.pub2/fullpdf

Reference324 articles.

1. GlaxomithKline A multicentre, parallel group study to compare the efficacy and tolerability of paroxetine with clomipramine in elderly patients www.gsk-clinicalstudyregister.com 1989

2. Rouillon F A double-blind, multicentre study comparing increasing doses of paroxetine (20-50 mg) and clomipramine (50-150mg) in elderly patients with major depression World congress of biological psychiatry (poster presentation) 1991

3. GlaxoSmithKline A double-blind comparative study of withdrawal effects following abrupt discontinuation of treatment with paroxetine in low or high dose or imipramine www.gsk-clinicalstudyregister.com 1992

4. Comparative efficacy between venlafaxine and SSRIs: A pooled analysis of patients with depression;Stahl;Biological Psychiatry,2002

5. A critical examination of the sensitivity of underdimensional subscales derived from the Hamilton Depression Rating Scale to antidepressant drug effects;Entsuah;Journal of Psychiatric Research,2002

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and pharmacological evaluation of liposomes and nanocapsules containing paroxetine hydrochloride;International Journal of Pharmaceutics;2024-07

2. Is antidepressant use a concern for patients with COPD?;Thorax;2023-09-15

3. Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of anxiety, obsessive-compulsive, and stress disorders: a systematic review and network meta-analysis;Psychological Medicine;2023-06-06

4. Study effect of traditional chemotherapy compared with the effect of combination (chemotherapeutic plus paroxetine) on cell line of multiple myeloma;THE SECOND INTERNATIONAL SCIENTIFIC CONFERENCE (SISC2021): College of Science, Al-Nahrain University;2023

5. Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients;Pharmaceutics;2022-09-28